You have 9 free searches left this month | for more free features.

Hodgkin Disease

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin Disease Trial in France (Morphological and functional magnetic resonance imaging (MRI), Neuropsychological assessment)

Not yet recruiting
  • Hodgkin Disease
  • Morphological and functional magnetic resonance imaging (MRI)
  • Neuropsychological assessment
  • Arras, France
  • +3 more
Oct 31, 2023

Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)

Not yet recruiting
  • Hodgkin Lymphoma
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Sep 19, 2023

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Low-field magnetic resonance imaging
  • +3 more
  • Erlangen, Bavaria, Germany
    Department of Pediatrics and Adolescent Medicine
Oct 23, 2023

Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

Not yet recruiting
  • Classical Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • GEN3017
  • (no location specified)
Aug 25, 2023

Non-Hodgkin's Lymphoma and Hodgkin's Disease

Recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease
    • Stanford, California
      Stanford University School of Medicine
    Sep 9, 2022

    Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

    Not yet recruiting
    • Classic Hodgkin Lymphoma
    • Concurrent penpulimab and AVD
    • Sequential penpulimab and AVD
    • (no location specified)
    Jul 10, 2023

    Resting Heart Rate and Heart Rate Variability in Survivors of

    Active, not recruiting
    • Hodgkin Disease
      • Memphis, Tennessee
        Kirsten Ness
      Jan 23, 2023

      Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)

      Active, not recruiting
      • Hodgkin Lymphoma
      • Brentuximab Vedotin
      • +3 more
      • Valhalla, New York
        New York Medical College
      Sep 27, 2022

      Cardiovascular Disease in Hodgkin Lymphoma Survivors

      Not yet recruiting
      • Hodgkin Lymphoma
      • +3 more
      • Patient Self Reporting
      • +2 more
      • (no location specified)
      Jan 20, 2023

      Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

      Recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Brentuximab Vedotin 50 MG [Adcetris]
      • Leon, Guanajuato, Mexico
        Hospital Regional Alta Especialidad Bajio
      Oct 24, 2022

      Relapsed or Refractory Hodgkin Lymphoma Trial in Beijing (SHR2554+ SHR1701, SHR-1701)

      Recruiting
      • Relapsed or Refractory Hodgkin Lymphoma
      • Beijing, Beijing, China
        Han wei dong
      Jun 14, 2023

      Quality of Life in Adult and Pediatric Nodular

      Recruiting
      • Nodular Lymphocyte-Predominant Hodgkin Lymphoma
        • Aurora, Colorado
        • +1 more
        Oct 27, 2023

        Brazilian Prospective Hodgkin Lymphoma Registry

        Recruiting
        • Hodgkin Lymphoma
        • Hodgkin Disease
          • Rio de Janeiro, Brazil
            Universidade Federal Do Rio de Janeiro
          May 16, 2022

          Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

          Recruiting
          • Non-Hodgkin Lymphoma
          • Hodgkin Lymphoma
          • Minneapolis, Minnesota
            Masonic Cancer Center, University of Minnesota
          Jan 25, 2023

          Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

          Active, not recruiting
          • Hodgkin Lymphoma Survivor
          • Clinical Assessment
          • +2 more
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Dec 22, 2022

          Hodgkin Lymphoma Trial in Houston (Brentuximab vedotin, Doxorubicin Hydrochloride, Pembrolizumab)

          Not yet recruiting
          • Hodgkin Lymphoma
          • Brentuximab vedotin
          • +3 more
          • Houston, Texas
            M D Anderson Cancer Center
          Jun 20, 2023

          Hodgkin Lymphoma Trial (Tislelizumab, AVD, Radiotherapy)

          Not yet recruiting
          • Hodgkin Lymphoma
          • Tislelizumab, AVD, Radiotherapy
          • (no location specified)
          Nov 15, 2022

          Hodgkin Lymphoma Trial in Salt Lake City (Axatilimab, Nivolumab)

          Not yet recruiting
          • Hodgkin Lymphoma
          • Salt Lake City, Utah
            Huntsman Cancer Institute at the University of Utah
          Feb 1, 2023

          Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)

          Active, not recruiting
          • Classical Hodgkin Lymphoma
          • Philadelphia, Pennsylvania
            Abramson Cancer Center of the University of Pennsylvania
          Nov 28, 2022

          Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

          Not yet recruiting
          • COVID-19
          • +2 more
            • Cologne, NRW, Germany
              University Hospital of Cologne
            Oct 27, 2022

            Hodgkin Lymphoma Trial in Moscow (Nivolumab)

            Recruiting
            • Hodgkin Lymphoma
            • Moscow, Russian Federation
              National Research Center for Hematology
            Dec 13, 2022

            Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)

            Completed
            • Multiple Myeloma
            • +11 more
            • Pre-biotic foods/drinks
            • Charlottesville, Virginia
              University of Virginia
            Jan 2, 2023

            Hodgkin Lymphoma Trial in Saint Petersburg (Prolgolimab, Combination with prolgolimab and bendamustine)

            Recruiting
            • Hodgkin Lymphoma
            • Saint Petersburg, Russian Federation
            • +1 more
            Mar 3, 2023

            Clinical, Laboratory and Epidemiologic Characterization of

            Recruiting
            • Waldenstrom Macroglobulinemia
            • +4 more
              • Bethesda, Maryland
              • +1 more
              Jan 25, 2023